OM-85 was shown to promote a Th1-biased immune environment by increasing interferon-gamma (IFN-γ) and reducing interleukin-4 (IL-4), thereby potentially regulating the fibrogenic Th2 shift induced by lung injury. This evidence concerns the gene IFNG and ocular melanoma.